Press Releases Bullfrog AI Holdings, Inc.

Equities

BFRG

US12021E1091

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
2.71 ^USD	-4.58%		-2.52%	-16.87%

May. 16	Bullfrog AI Holdings, Inc. and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders	CI
May. 10	Bullfrog AI Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12	May. 29	AQ
BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders	May. 16	AQ
BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo	Apr. 09	AQ
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute	Mar. 08	AQ
BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer	Feb. 26	AQ
BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock	Feb. 21	AQ
BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip	Feb. 09	AQ
WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering	Feb. 05	PR
BullFrog AI Announces Closing of $5.7 Million Public Offering	Feb. 05	AQ
WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering	Feb. 01	PR
Bullfrog AI Announces Pricing of $5.7 Million Public Offering	Feb. 01	AQ
BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala	Jan. 26	AQ
BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data	Jan. 17	AQ
BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer	Jan. 16	AQ
BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17	Jan. 11	AQ
BullFrog AI Issues Letter to Shareholders	Dec. 29	AQ
BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity	Dec. 06	AQ
BullFrog AI to Present at Benzinga All Access Event on October 20	23-10-18	AQ
BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform	23-10-05	AQ
BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma	23-09-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bullfrog AI Holdings, Inc.

Equities

BFRG

US12021E1091

Press Releases

Filters